Sintx Technologies Files Q3 2024 10-Q Report
Ticker: SINT · Form: 10-Q · Filed: Nov 12, 2024 · CIK: 1269026
| Field | Detail |
|---|---|
| Company | Sintx Technologies, Inc. (SINT) |
| Form Type | 10-Q |
| Filed Date | Nov 12, 2024 |
| Risk Level | medium |
| Pages | 16 |
| Reading Time | 19 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, medical-devices
TL;DR
SINT filed its Q3 10-Q. Check financials for the period ending 9/30/24.
AI Summary
Sintx Technologies, Inc. filed its Q3 10-Q report for the period ending September 30, 2024. The company, formerly known as AMEDICA Corp, is involved in the surgical and medical instruments sector. Key financial data and operational details for the third quarter and year-to-date periods are presented in this filing.
Why It Matters
This filing provides investors and stakeholders with the latest financial performance and operational updates for Sintx Technologies, Inc. during the third quarter of 2024.
Risk Assessment
Risk Level: medium — As a 10-Q filing, it contains detailed financial information which can reveal significant risks and opportunities for investors.
Key Numbers
- 2024-09-30 — Reporting Period End Date (Indicates the end of the fiscal quarter for which financial data is reported.)
- 2024-11-12 — Filing Date (The date the 10-Q report was officially submitted to the SEC.)
Key Players & Entities
- Sintx Technologies, Inc. (company) — Filer of the 10-Q report
- AMEDICA Corp (company) — Former name of Sintx Technologies, Inc.
- 20240930 (date) — End of the reporting period
- 20241112 (date) — Filing date of the report
FAQ
What were the total revenues for the third quarter of 2024?
The filing does not explicitly state total revenues for Q3 2024 in the provided snippet. It indicates reporting periods for 'us-gaap:ProductMember' and 'SINT:GrantAndContractMember' for Q3 2024.
What is the company's primary industry classification?
Sintx Technologies, Inc. is classified under 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]'.
When was the company formerly known as AMEDICA Corp?
The company was formerly known as AMEDICA Corp, with a date of name change on 20121231.
What is the fiscal year end for Sintx Technologies, Inc.?
The fiscal year end for Sintx Technologies, Inc. is December 31 (1231).
What are the different series of convertible preferred stock mentioned?
The filing mentions SeriesBConvertiblePreferredStockMember, SeriesCConvertiblePreferredStockMember, and SeriesDConvertiblePreferredStockMember.
Filing Stats: 4,798 words · 19 min read · ~16 pages · Grade level 14.9 · Accepted 2024-11-12 15:50:42
Filing Documents
- form10-q.htm (10-Q) — 984KB
- ex31-1.htm (EX-31.1) — 11KB
- ex31-2.htm (EX-31.2) — 11KB
- ex32.htm (EX-32) — 7KB
- 0001493152-24-044728.txt ( ) — 5242KB
- sint-20240930.xsd (EX-101.SCH) — 40KB
- sint-20240930_cal.xml (EX-101.CAL) — 54KB
- sint-20240930_def.xml (EX-101.DEF) — 176KB
- sint-20240930_lab.xml (EX-101.LAB) — 356KB
- sint-20240930_pre.xml (EX-101.PRE) — 265KB
- form10-q_htm.xml (XML) — 784KB
Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 20
Quantitative and Qualitative Disclosures About Market Risk
Item 3. Quantitative and Qualitative Disclosures About Market Risk 28
Controls and Procedures
Item 4. Controls and Procedures 28
Other Information
Part II. Other Information
Legal Proceedings
Item 1. Legal Proceedings 29
Risk Factors
Item 1A. Risk Factors 29
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 29
Defaults Upon Senior Securities
Item 3. Defaults Upon Senior Securities 29
Mine Safety Disclosures
Item 4. Mine Safety Disclosures 29
Other Information
Item 5. Other Information 29
Exhibits
Item 6. Exhibits 30
Signatures
Signatures 31 2 SINTX Technologies, Inc. Condensed Consolidated Balance Sheets - Unaudited (in thousands, except share and per share data) September 30, 2024 December 31, 2023 Assets Current assets: Cash and cash equivalents $ 4,814 $ 3,340 Account and other receivables, net of allowance totaling 84 and 72 respectively 340 685 Prepaid expenses and other current assets 595 539 Inventories 463 888 Other current assets 120 80 Total current assets 6,332 5,532 Inventories, net 403 333 Property and equipment, net 1,048 4,826 Intangible assets, net 17 21 Operating lease right of use asset 3,268 4,094 Other long-term assets 235 559 Total assets $ 11,303 $ 15,365 Liabilities and Stockholders' Equity Current liabilities: Accounts payable $ 153 $ 636 Accrued liabilities 1,099 1,404 Debt 134 46 Derivative liabilities 224 304 Current portion of operating lease liability 469 512 Other current liabilities 1 4 Total current liabilities 2,080 2,906 Operating lease liability, net of current portion 3,642 3,687 Total liabilities 5,722 6,593 Commitments and contingencies - - Stockholders' equity: Convertible preferred stock Series B, $ 0.01 par value, 130,000,000 total shares authorized inclusive of all series of preferred; 19 and 26 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively. - - Convertible preferred stock Series C, $ 0.01 par value, 130,000,000 total shares authorized inclusive of all series of preferred; 50 shares issued and outstanding as of September 30, 2024 and December 31, 2023. - - Convertible preferred stock Series D, $ 0.01 par value, 130,000,000 total shares authorized inclusive of all series of preferred; 180 shares issued and outstanding as of September 30, 2024 and December 31, 2023. - - Preferred stock value - - Common stock, $ 0.01 par value, 250,000,000 shares authorized; 1,342,853 and 26,603 s